{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:55:35Z","timestamp":1791971735247,"version":"4.3.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":111,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012331","name":"Agentschap Innoveren en Ondernemen","doi-asserted-by":"publisher","award":["HBC.2022.0631"],"award-info":[{"award-number":["HBC.2022.0631"]}],"id":[{"id":"10.13039\/100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01442-4","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:16:06Z","timestamp":1782396966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Overexpression of phosphorylated and truncated \u03b1-Synuclein does not trigger Parkinsonian readouts in A53T-SNCA mice"],"prefix":"10.1038","volume":"12","author":[{"given":"Annelore","family":"Anthonissen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmus","family":"Drinkenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Verstreken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dries","family":"Crauwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Diego","family":"Pita-Almenar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Maurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Ahnaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"1442_CR1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H. & Del Tredici, K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. (Berl.) 112, 389\u2013404 (2006).","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"1442_CR2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer, W. & Przedborski, S. Parkinson\u2019s disease: Mechanisms and Models. Neuron 39, 889\u2013909 (2003).","journal-title":"Neuron"},{"key":"1442_CR3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. Parkinson\u2019s disease: Clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79, 368\u2013376 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1442_CR4","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/brain\/awz111","volume":"142","author":"SM Fereshtehnejad","year":"2019","unstructured":"Fereshtehnejad, S. M. et al. Evolution of prodromal Parkinson\u2019s disease and dementia with Lewy bodies: a prospective study. Brain 142, 2051\u20132067 (2019).","journal-title":"Brain"},{"key":"1442_CR5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/WCO.0000000000000112","volume":"27","author":"JG Goldman","year":"2014","unstructured":"Goldman, J. G. & Postuma, R. Premotor and non-motor features of Parkinson\u2019s disease. Curr. Opin. Neurol. 27, 434\u2013441 (2014).","journal-title":"Curr. Opin. Neurol."},{"key":"1442_CR6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/mds.24996","volume":"27","author":"RB Postuma","year":"2012","unstructured":"Postuma, R. B. et al. Identifying prodromal Parkinson\u2019s disease: pre-motor disorders in Parkinson\u2019s disease. Mov. Disord. J. Mov. Disord. Soc. 27, 617\u2013626 (2012).","journal-title":"Mov. Disord. J. Mov. Disord. Soc."},{"key":"1442_CR7","doi-asserted-by":"publisher","unstructured":"Mahlknecht, P., Marini, K., Werkmann, M., Poewe, W., Seppi, K. Prodromal Parkinson\u2019s disease: Hype or hope for disease-modification trials? Transl. Neurodegener. 11, https:\/\/doi.org\/10.1186\/s40035-022-00286-1 (2022).","DOI":"10.1186\/s40035-022-00286-1"},{"key":"1442_CR8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/01.WNL.0000073619.94467.B0","volume":"61","author":"BF Boeve","year":"2003","unstructured":"Boeve, B. F. et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 61, 40\u201345 (2003).","journal-title":"Neurology"},{"key":"1442_CR9","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/brain\/awm056","volume":"130","author":"BF Boeve","year":"2007","unstructured":"Boeve, B. F. et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain J. Neurol. 130, 2770\u20132788 (2007).","journal-title":"Brain J. Neurol."},{"key":"1442_CR10","first-page":"545","volume":"14","author":"L Pauly","year":"2024","unstructured":"Pauly, L. et al. Cognition and other non-motor symptoms in an at-risk cohort for Parkinson\u2019s disease defined by REM-sleep behavior disorder and hyposmia. J. Park Dis. 14, 545\u2013556 (2024).","journal-title":"J. Park Dis."},{"key":"1442_CR11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104897","volume":"143","author":"A Ahnaou","year":"2022","unstructured":"Ahnaou, A. & Drinkenburg, W. H. I. M. REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson\u2019s disease. Neurosci. Biobehav Rev. 143, 104897 (2022).","journal-title":"Neurosci. Biobehav Rev."},{"key":"1442_CR12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2020.108801","volume":"342","author":"S Cerri","year":"2020","unstructured":"Cerri, S. & Blandini, F. In vivo modeling of prodromal stage of Parkinson\u2019s disease. J. Neurosci. Methods 342, 108801 (2020).","journal-title":"J. Neurosci. Methods"},{"key":"1442_CR13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/brain\/awz380","volume":"143","author":"T Taguchi","year":"2020","unstructured":"Taguchi, T. et al. \u03b1-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson\u2019s disease model. Brain J. Neurol. 143, 249\u2013265 (2020).","journal-title":"Brain J. Neurol."},{"key":"1442_CR14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mdc3.13511","volume":"9","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Association of concurrent olfactory dysfunction and probable rapid eye movement sleep behavior disorder with early Parkinson\u2019s disease progression. Mov. Disord. Clin. Pr. 9, 909\u2013919 (2022).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1442_CR15","doi-asserted-by":"publisher","unstructured":"Orso, B., Brosse, S., Frasnelli, J., Arnaldi, D. Opportunities and pitfalls of REM sleep behavior disorder and olfactory dysfunction as early markers in Parkinson\u2019s disease. J. Park. Dis. https:\/\/doi.org\/10.3233\/JPD-230348 (Published online March 22, 2024).","DOI":"10.3233\/JPD-230348"},{"key":"1442_CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp-2020-325361","volume":"92","author":"Z Lyu","year":"2021","unstructured":"Lyu, Z. et al. Olfactory impairment as an early marker of Parkinson\u2019s disease in REM sleep behaviour disorder: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 92, 271\u2013281 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1442_CR17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3390\/brainsci13040599","volume":"13","author":"P Solla","year":"2023","unstructured":"Solla, P. et al. Olfactory impairment is the main predictor of higher scores at REM sleep behavior disorder (RBD) screening questionnaire in Parkinson\u2019s disease patients. Brain Sci. 13, 599 (2023).","journal-title":"Brain Sci."},{"key":"1442_CR18","first-page":"1","volume":"4","author":"Y Dauvilliers","year":"2018","unstructured":"Dauvilliers, Y. et al. REM sleep behaviour disorder. Nat. Rev. Dis. Prim. 4, 1 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1442_CR19","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1212\/01.wnl.0000340980.19702.6e","volume":"72","author":"RB Postuma","year":"2009","unstructured":"Postuma, R. B. et al. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 72, 1296\u20131300 (2009).","journal-title":"Neurology"},{"key":"1442_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34732-5","volume":"13","author":"L Krohn","year":"2022","unstructured":"Krohn, L. et al. Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects. Nat. Commun. 13, 7496 (2022).","journal-title":"Nat. Commun."},{"key":"1442_CR21","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma, R. B. et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 142, 744\u2013759 (2019).","journal-title":"Brain"},{"key":"1442_CR22","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1093\/brain\/awaa283","volume":"143","author":"Y Shen","year":"2020","unstructured":"Shen, Y. et al. Propagated \u03b1-synucleinopathy recapitulates REM sleep behaviour disorder followed by parkinsonian phenotypes in mice. Brain J. Neurol. 143, 3374\u20133392 (2020).","journal-title":"Brain J. Neurol."},{"key":"1442_CR23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/brain\/aww310","volume":"140","author":"S Valencia Garcia","year":"2017","unstructured":"Valencia Garcia, S. et al. Genetic inactivation of glutamate neurons in the rat sublaterodorsal tegmental nucleus recapitulates REM sleep behaviour disorder. Brain 140, 414\u2013428 (2017).","journal-title":"Brain"},{"key":"1442_CR24","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1016\/j.cub.2019.09.026","volume":"29","author":"ZA Torontali","year":"2019","unstructured":"Torontali, Z. A., Fraigne, J. J., Sanghera, P., Horner, R. & Peever, J. The sublaterodorsal tegmental nucleus functions to couple brain state and motor activity during REM sleep and wakefulness. Curr. Biol. 29, 3803\u20133813.e5 (2019).","journal-title":"Curr. Biol."},{"key":"1442_CR25","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nrn983","volume":"3","author":"J Lotharius","year":"2002","unstructured":"Lotharius, J. & Brundin, P. Pathogenesis of Parkinson\u2019s Disease: Dopamine, vesicles and \u03b1-synuclein. Nat. Rev. Neurosci. 3, 932\u2013942 (2002).","journal-title":"Nat. Rev. Neurosci."},{"key":"1442_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40035-023-00378-6","volume":"12","author":"ZD Zhou","year":"2023","unstructured":"Zhou, Z. D., Yi, L. X., Wang, D. Q., Lim, T. M. & Tan, E. K. Role of dopamine in the pathophysiology of Parkinson\u2019s disease. Transl. Neurodegener. 12, 44 (2023).","journal-title":"Transl. Neurodegener."},{"key":"1442_CR27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","volume":"14","author":"J Parkinson","year":"2002","unstructured":"Parkinson, J. An essay on the shaking palsy. J. Neuropsychiatry Clin. Neurosci. 14, 223\u2013236 (2002).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"1442_CR28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neures.2012.03.010","volume":"73","author":"H Yamakado","year":"2012","unstructured":"Yamakado, H. et al. \u03b1-Synuclein BAC transgenic mice as a model for Parkinson\u2019s disease manifested decreased anxiety-like behavior and hyperlocomotion. Neurosci. Res 73, 173\u2013177 (2012).","journal-title":"Neurosci. Res"},{"key":"1442_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2023.114781","volume":"460","author":"S Moceri","year":"2024","unstructured":"Moceri, S. et al. Young human alpha synuclein transgenic (BAC-SNCA) mice display sex- and gene-dose-dependent phenotypic disturbances. Behav. Brain Res 460, 114781. https:\/\/doi.org\/10.1016\/j.bbr.2023.114781 (2024).","journal-title":"Behav. Brain Res"},{"key":"1442_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-20944-4","volume":"15","author":"S Zhang","year":"2025","unstructured":"Zhang, S. et al. Digital droplet PCR is an accurate and precise method to measure DNA copy number. Sci. Rep. 15, 36958 (2025).","journal-title":"Sci. Rep."},{"key":"1442_CR31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molbrainres.2004.07.002","volume":"130","author":"GM Alexander","year":"2004","unstructured":"Alexander, G. M. et al. Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS. Brain Res. Mol. Brain Res 130, 7\u201315 (2004).","journal-title":"Brain Res. Mol. Brain Res"},{"key":"1442_CR32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00335-007-9056-y","volume":"18","author":"KJ Chandler","year":"2007","unstructured":"Chandler, K. J. et al. Relevance of BAC transgene copy number in mice: transgene copy number variation across multiple transgenic lines and correlations with transgene integrity and expression. Mamm. Genome J. Int Mamm. Genome Soc. 18, 693\u2013708 (2007).","journal-title":"Mamm. Genome J. Int Mamm. Genome Soc."},{"key":"1442_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10048-018-0546-8","volume":"19","author":"A Afek","year":"2018","unstructured":"Afek, A. et al. Toward deciphering the mechanistic role of variations in the Rep1 repeat site in the transcription regulation of SNCA gene. Neurogenetics 19, 135\u2013144 (2018).","journal-title":"Neurogenetics"},{"key":"1442_CR34","doi-asserted-by":"crossref","first-page":"22670","DOI":"10.1074\/jbc.M501508200","volume":"280","author":"CW Liu","year":"2005","unstructured":"Liu, C. W. et al. A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. J. Biol. Chem. 280, 22670\u201322678 (2005).","journal-title":"J. Biol. Chem."},{"key":"1442_CR35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41531-022-00357-0","volume":"8","author":"P Magalh\u00e3es","year":"2022","unstructured":"Magalh\u00e3es, P. & Lashuel, H. A. Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson\u2019s disease and other synucleinopathies. Npj Park Dis. 8, 93 (2022).","journal-title":"Npj Park Dis."},{"key":"1442_CR36","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1074\/jbc.M115.705095","volume":"291","author":"F Samuel","year":"2016","unstructured":"Samuel, F. et al. Effects of serine 129 phosphorylation on \u03b1-synuclein aggregation, membrane association, and internalization. J. Biol. Chem. 291, 4374\u20134385 (2016).","journal-title":"J. Biol. Chem."},{"key":"1442_CR37","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1074\/jbc.REV120.011743","volume":"295","author":"ZA Sorrentino","year":"2020","unstructured":"Sorrentino, Z. A. & Giasson, B. I. The emerging role of \u03b1-synuclein truncation in aggregation and disease. J. Biol. Chem. 295, 10224\u201310244 (2020).","journal-title":"J. Biol. Chem."},{"key":"1442_CR38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1326-8-44","volume":"8","author":"M Oliveras-Salv\u00e1","year":"2013","unstructured":"Oliveras-Salv\u00e1, M. et al. rAAV2\/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration. Mol. Neurodegener. 8, 44 (2013).","journal-title":"Mol. Neurodegener."},{"key":"1442_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40478-024-01785-0","volume":"12","author":"SG Choi","year":"2024","unstructured":"Choi, S. G. et al. Alpha-synuclein aggregates are phosphatase resistant. Acta Neuropathol. Commun. 12, 84 (2024).","journal-title":"Acta Neuropathol. Commun."},{"key":"1442_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz, M. et al. Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578, 273\u2013277 (2020).","journal-title":"Nature"},{"key":"1442_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-023-00614-w","volume":"10","author":"JA Wiseman","year":"2024","unstructured":"Wiseman, J. A. et al. Aggregate-prone brain regions in Parkinson\u2019s disease are rich in unique N-terminus \u03b1-synuclein conformers with high proteolysis susceptibility. NPJ Park Dis. 10, 1 (2024).","journal-title":"NPJ Park Dis."},{"key":"1442_CR42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41531-023-00491-3","volume":"9","author":"BA Killinger","year":"2023","unstructured":"Killinger, B. A. et al. Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesis. Npj Park Dis. 9, 43 (2023).","journal-title":"Npj Park Dis."},{"key":"1442_CR43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuroscience.2011.10.042","volume":"200","author":"G Muntan\u00e9","year":"2012","unstructured":"Muntan\u00e9, G., Ferrer, I. & Martinez-Vicente, M. \u03b1-synuclein phosphorylation and truncation are normal events in the adult human brain. Neuroscience 200, 106\u2013119 (2012).","journal-title":"Neuroscience"},{"key":"1442_CR44","first-page":"39","volume":"6","author":"A Oueslati","year":"2016","unstructured":"Oueslati, A. Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: What have we learned in the last decade? J. Park Dis. 6, 39\u201351 (2016).","journal-title":"J. Park Dis."},{"key":"1442_CR45","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1016\/j.neuron.2023.11.020","volume":"111","author":"LA Parra-Rivas","year":"2023","unstructured":"Parra-Rivas, L. A. et al. Serine-129 phosphorylation of \u03b1-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function. Neuron 111, 4006\u20134023.e10 (2023).","journal-title":"Neuron"},{"key":"1442_CR46","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.tins.2024.05.005","volume":"47","author":"N Ramalingam","year":"2024","unstructured":"Ramalingam, N., Haass, C. & Dettmer, U. Physiological roles of \u03b1-synuclein serine-129 phosphorylation \u2014 not an oxymoron. Trends Neurosci. 47, 480\u2013490 (2024).","journal-title":"Trends Neurosci."},{"key":"1442_CR47","doi-asserted-by":"publisher","unstructured":"Tenreiro, S., Eckermann, K., Outeiro, T. F. Protein phosphorylation in neurodegeneration: Friend or foe? Front. Mol. Neurosci. 7, https:\/\/doi.org\/10.3389\/fnmol.2014.00042 (2014).","DOI":"10.3389\/fnmol.2014.00042"},{"key":"1442_CR48","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/pharmrev.123.001111","volume":"76","author":"K Hassanzadeh","year":"2024","unstructured":"Hassanzadeh, K., Liu, J., Maddila, S. & Mouradian, M. M. Posttranslational modifications of \u03b1-synuclein, their therapeutic potential, and crosstalk in health and neurodegenerative diseases. Pharm. Rev. 76, 1254\u20131290 (2024).","journal-title":"Pharm. Rev."},{"key":"1442_CR49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41531-025-01084-y","volume":"11","author":"AL Mahul-Mellier","year":"2025","unstructured":"Mahul-Mellier, A. L. et al. Differential role of C-terminal truncations on alpha-synuclein pathology and Lewy body formation. Npj Park Dis. 11, 261 (2025).","journal-title":"Npj Park Dis."},{"key":"1442_CR50","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/NEN.0b013e31818b4126","volume":"67","author":"R Sengoku","year":"2008","unstructured":"Sengoku, R. et al. Incidence and extent of lewy body-related \u03b1-synucleinopathy in aging human olfactory bulb. J. Neuropathol. Exp. Neurol. 67, 1072\u20131083 (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1442_CR51","volume":"32","author":"C Tremblay","year":"2022","unstructured":"Tremblay, C. et al. Effect of olfactory bulb pathology on olfactory function in normal aging. Brain Pathol. Zur. Switz. 32, e13075 (2022).","journal-title":"Brain Pathol. Zur. Switz."},{"key":"1442_CR52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/chemse\/bjz005","volume":"44","author":"SD Burton","year":"2019","unstructured":"Burton, S. D., Wipfel, M., Guo, M., Eiting, T. P. & Wachowiak, M. A novel olfactometer for efficient and flexible odorant delivery. Chem. Senses 44, 173\u2013188 (2019).","journal-title":"Chem. Senses"},{"key":"1442_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66201-8","volume":"10","author":"ME Johnson","year":"2020","unstructured":"Johnson, M. E. et al. Deficits in olfactory sensitivity in a mouse model of Parkinson\u2019s disease revealed by plethysmography of odor-evoked sniffing. Sci. Rep. 10, 9242 (2020).","journal-title":"Sci. Rep."},{"key":"1442_CR54","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1523\/JNEUROSCI.0347-11.2011","volume":"31","author":"PL Brooks","year":"2011","unstructured":"Brooks, P. L. & Peever, J. H. Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavior disorder in mice. J. Neurosci. J. Soc. Neurosci. 31, 7111\u20137121 (2011).","journal-title":"J. Neurosci. J. Soc. Neurosci."},{"key":"1442_CR55","doi-asserted-by":"publisher","unstructured":"Kashiwagi, M. et al. A pontine-medullary loop crucial for REM sleep and its deficit in Parkinson\u2019s disease. Cell. S0092-8674(24)00975-9. https:\/\/doi.org\/10.1016\/j.cell.2024.08.046 (Published online September 17, 2024).","DOI":"10.1016\/j.cell.2024.08.046"},{"key":"1442_CR56","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14266","volume":"34","author":"PH Luppi","year":"2025","unstructured":"Luppi, P. H. et al. Neuronal network controlling REM sleep. J. Sleep. Res 34, e14266 (2025).","journal-title":"J. Sleep. Res"},{"key":"1442_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02761-0","volume":"9","author":"S Valencia Garcia","year":"2018","unstructured":"Valencia Garcia, S. et al. Ventromedial medulla inhibitory neuron inactivation induces REM sleep without atonia and REM sleep behavior disorder. Nat. Commun. 9, 504 (2018).","journal-title":"Nat. Commun."},{"key":"1442_CR58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41531-024-00756-5","volume":"10","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. GBA-AAV mitigates sleep disruptions and motor deficits in mice with REM sleep behavior disorder. NPJ Park Dis. 10, 142 (2024).","journal-title":"NPJ Park Dis."},{"key":"1442_CR59","doi-asserted-by":"crossref","first-page":"e11464","DOI":"10.1371\/journal.pone.0011464","volume":"5","author":"A Kurz","year":"2010","unstructured":"Kurz, A. et al. A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. PLoS ONE 5, e11464 (2010).","journal-title":"PLoS ONE"},{"key":"1442_CR60","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1044-7431(03)00198-2","volume":"24","author":"S Gispert","year":"2003","unstructured":"Gispert, S. et al. Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol. Cell Neurosci. 24, 419\u2013429 (2003).","journal-title":"Mol. Cell Neurosci."},{"key":"1442_CR61","doi-asserted-by":"crossref","first-page":"114959","DOI":"10.1016\/j.expneurol.2024.114959","volume":"382","author":"SIG Moreno","year":"2024","unstructured":"Moreno, S. I. G. et al. Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration. Exp. Neurol. 382, 114959 (2024).","journal-title":"Exp. Neurol."},{"key":"1442_CR62","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s10571-026-01707-9","volume":"46","author":"M Zubelzu","year":"2026","unstructured":"Zubelzu, M. et al. Sex-Dependent Dynamics of Behavioural and Neuropathological Changes in an A53T Alpha-Synuclein Mouse Model of Parkinson\u2019s Disease. Cell. Mol. Neurobiol. 46, 70 (2026).","journal-title":"Cell. Mol. Neurobiol."},{"key":"1442_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06724-9","volume":"7","author":"JA Phan","year":"2017","unstructured":"Phan, J. A. et al. Early synaptic dysfunction induced by \u03b1-synuclein in a rat model of Parkinson\u2019s disease. Sci. Rep. 7, 6363 (2017).","journal-title":"Sci. Rep."},{"key":"1442_CR64","first-page":"297","volume":"9","author":"MF Chesselet","year":"2012","unstructured":"Chesselet, M. F. et al. A progressive mouse model of Parkinson\u2019s disease: The Thy1-aSyn (\u201cLine 61\u201d) mice. Neurother. J. Am. Soc. Exp. Neurother. 9, 297\u2013314 (2012).","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"1442_CR65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1460-9568.2008.06346.x","volume":"28","author":"SM Fleming","year":"2008","unstructured":"Fleming, S. M. et al. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur. J. Neurosci. 28, 247\u2013256 (2008).","journal-title":"Eur. J. Neurosci."},{"key":"1442_CR66","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson, B. I. et al. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34, 521\u2013533 (2002).","journal-title":"Neuron"},{"key":"1442_CR67","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. J. Exp. Med 209, 975\u2013986 (2012).","journal-title":"J. Exp. Med"},{"key":"1442_CR68","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103, 627\u2013641.e7 (2019).","journal-title":"Neuron"},{"key":"1442_CR69","first-page":"289","volume":"19","author":"S Okuda","year":"2022","unstructured":"Okuda, S. et al. Rapid induction of dopaminergic neuron loss accompanied by Lewy body-like inclusions in A53T BAC-SNCA transgenic mice. Neurother. J. Am. Soc. Exp. Neurother. 19, 289\u2013304 (2022).","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"1442_CR70","doi-asserted-by":"crossref","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 18, e3000410 (2020).","journal-title":"PLoS Biol."},{"key":"1442_CR71","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2897","volume":"8","author":"CF Machado","year":"2018","unstructured":"Machado, C. F., Reis-Silva, T. M., Lyra, C. S., Felicio, L. F. & Malnic, B. Buried food-seeking test for the assessment of olfactory detection in mice. Bio-Protoc. 8, e2897 (2018).","journal-title":"Bio-Protoc."},{"key":"1442_CR72","doi-asserted-by":"publisher","unstructured":"Yang, M., & Crawley, J. N. Simple behavioral assessment of mouse olfaction. Curr. Protoc. Neurosci. Editor Board Jacqueline N Crawley Al;CHAPTER:Unit-8.24. https:\/\/doi.org\/10.1002\/0471142301.ns0824s48 (2009).","DOI":"10.1002\/0471142301.ns0824s48"},{"key":"1442_CR73","first-page":"11.18.1","volume":"63","author":"J Zou","year":"2015","unstructured":"Zou, J., Wang, W., Pan, Y. W., Lu, S. & Xia, Z. Methods to measure olfactory behavior in mice. Curr. Protoc. Toxicol. Editor. Board Mahin Maines Ed. \u2013Chief Al 63, 11.18.1\u201311.18.21 (2015).","journal-title":"Curr. Protoc. Toxicol. Editor. Board Mahin Maines Ed. \u2013Chief Al"},{"key":"1442_CR74","doi-asserted-by":"crossref","unstructured":"Bloch S., & Belzung, C. The light\u2013dark box test in the mouse. In: Harro J., ed. Psychiatric Vulnerability, Mood, and Anxiety Disorders: Tests and Models in Mice and Rats. Springer US; 2023:31-41.","DOI":"10.1007\/978-1-0716-2748-8_3"},{"key":"1442_CR75","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","volume":"463","author":"M Bourin","year":"2003","unstructured":"Bourin, M. & Hasco\u00ebt, M. The mouse light\/dark box test. Eur. J. Pharm. 463, 55\u201365 (2003).","journal-title":"Eur. J. Pharm."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01442-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01442-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01442-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:38:17Z","timestamp":1791970697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01442-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1442"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01442-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9236452\/v1","asserted-by":"object"}]},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"249"}}